Table 3.
Dosage claimed in EP1210115B1 vis-a-vis prior art.
| Loading dose | Follow up doses | Interval | |
|---|---|---|---|
| Prior art (FDA-approved regimen) | 8 mg/kg | 6 mg/kg | Triweekly |
| EP1210115B1 | 4 mg/kg | 2 mg/kg | Weekly |
| Factor | 1/2 | 1/3 | 3 |
Dosage claimed in EP1210115B1 vis-a-vis prior art.
| Loading dose | Follow up doses | Interval | |
|---|---|---|---|
| Prior art (FDA-approved regimen) | 8 mg/kg | 6 mg/kg | Triweekly |
| EP1210115B1 | 4 mg/kg | 2 mg/kg | Weekly |
| Factor | 1/2 | 1/3 | 3 |